BSE filing, BSE: 544220. Summary written from the filing by ALFA Finder's alert engine.
Clinitech Laboratory Ltd: key numbers
- Share price
- ₹30.85
- Market cap
- ₹7.04 Cr
- Revenue (annual)
- ₹9.49 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 16.9×Sector 34.1×
- Promoter holding
- 64.62%
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clinitech Laboratory Ltd
All →Clinitech Laboratory Promoter Reclassification
Clinitech Laboratory Ltd reclassified 12,000 shares held by Mr. Siddhesh Nayak on behalf of Kamaxi Stock Trendz from 'Public' to 'Promoter Group' category.
Clinitech Laboratory Other Announcement
Clinitech Laboratory Limited filed a Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming no rematerialization requests were received.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.
Clinitech Laboratory Board Meeting Outcome
Clinitech Laboratory Limited's board approved the FY 2025-26 report and convened its 16th Annual General Meeting. The meeting also finalized book closure dates and appointed a voting scrutinizer.
Clinitech Laboratory Board Meeting Date
Clinitech Laboratory Ltd scheduled a Board Meeting for August 17, 2026. The board will discuss director appointments and the 16th AGM.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.